Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia

Cornelis M van Tilburg, Till Milde, Ruth Witt, Jonas Ecker, Thomas Hielscher, Angelika Seitz, Jens-Peter Schenk, Juliane L Buhl, Dennis Riehl, Michael C Fruehwald, Arnulf Pekrun, Claudia Rossig, Regina Wieland, Christian Flotho, Uwe Kordes, Bernd Gruhn, Thorsten Simon, Christin Linderkamp, Felix Sahm, Lenka Taylor, Angelika Freitag, Juergen Burhenne, Kathrin I Foerster, Andreas D. Meid, Stefan M Pfister, Irini Karapanagiotou-Schenkel, Olaf Witt
October 2019
PDF DOI
Type
Journal article
Publication
Clin Epigenetics 11(1):188

Supplementary notes: -

Source Themes
Andreas D. Meid
Andreas D. Meid
Post-doctoral researcher in Clinical Pharmacology & Pharmacoepidemiology

My research interests include the study of appropriate drug therapy using methods of pharmacoepidemiology, quantitative pharmacology, and pharmacometrics.

Related